Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
11,200.00
22 (0.2%)
BSENSE

Nov 20

BSE+NSE Vol: 4.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "11,200.00",
    "chg": 22,
    "chgp": "0.2%",
    "dir": 1,
    "prev_price": "11,178.00",
    "mcapval": "295,022.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE361B01024",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "4.15 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Declines 2.52% Amid Mixed Signals and Rising Derivatives Activity",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-declines-252-amid-mixed-signals-and-rising-derivatives-activity-4270802",
        "imagepath": "",
        "date": "2026-11-21 17:05:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Intraday low amid price pressure (Rs.11,134.85)</p>\n                    <p><strong>17 Nov:</strong> Marginal recovery with slight price gain</p>\n                    <p><strong>18 Nov:</strong> Price dips amid broader market weakness</p>\n                    <p><strong>19 Nov:</strong> Strong rebound with highest volume of the week</p>\n                    <p><strong>20 Nov:</strong> Significant open interest surge in derivatives despite slight price decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.11,489.65</div></div>\n             ..."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amidst Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amidst-mixed-market-signals-4269727",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DivisLaboratori_oi_spurts_by_underlying_4269727.png",
        "date": "2026-11-20 15:00:23",
        "description": "Divis Laboratories Ltd, a large-cap stalwart in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.03% increase in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the surge in OI alongside rising delivery volumes suggests a complex interplay of directional bets and market sentiment."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amidst Stable Price Action",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amidst-stable-price-action-4269657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DivisLaboratori_oi_spurts_by_underlying_4269657.png",
        "date": "2026-11-20 14:00:15",
        "description": "Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.56% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite a marginal dip in its share price. This development reflects growing interest in the stock’s future prospects amid a stable trading range and improving fundamentals."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amid-mixed-price-action-4269583",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DivisLaboratori_oi_spurts_by_underlying_4269583.png",
        "date": "2026-11-20 13:00:15",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the underlying volume and OI data suggest evolving directional bets that merit close attention from market participants."
      },
      {
        "title": "Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 16 Nov 2026",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-16-nov-2026-4263978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DivisLaboratori_priceRelatedfactors_4263978.png",
        "date": "2026-11-16 11:37:22",
        "description": "Shares of Divis Laboratories Ltd declined sharply today, touching an intraday low of Rs 11,134.85, marking a 3.09% drop as the stock underperformed its sector and broader market indices amid subdued intraday momentum and immediate selling pressure."
      },
      {
        "title": "Divis Laboratories Gains 11.50%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-gains-1150-6-key-factors-driving-the-weeks-momentum-4262051",
        "imagepath": "",
        "date": "2026-11-14 17:02:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Nov:</strong> New 52-week and all-time high at Rs.11,786.1</p>\n                    <p><strong>09 Nov:</strong> Surge in call and put option activity ahead of 23 Nov expiry</p>\n                    <p><strong>11 Nov:</strong> Intraday low amid price pressure and heavy put option volumes</p>\n                    <p><strong>13 Nov:</strong> Week closes at Rs.11,489.65 (+11.50%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.10,305.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1..."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-buy-4261508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DivisLaboratori_mojoScore_4261508.png",
        "date": "2026-11-14 10:10:04",
        "description": "Divis Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 07 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of its performance and prospects."
      },
      {
        "title": "Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 11 Nov 2026",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-11-nov-2026-4258489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DivisLaboratori_priceRelatedfactors_4258489.png",
        "date": "2026-11-11 12:36:32",
        "description": "Divis Laboratories Ltd experienced a notable intraday decline on 11 Nov 2026, touching a low of Rs 11,194, reflecting a 3.25% drop from its previous close. This downturn marks a reversal after a sustained 12-day rally, with the stock underperforming its sector and broader market indices amid shifting market dynamics and investor sentiment."
      },
      {
        "title": "Rs 10,000 Puts — 13.5% Below Current Price — Draw 3,336 Contracts on Divis Laboratories Ltd",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/divis-laboratories-sees-heavy-put-option-activity-amid-bullish-price-momentum-4256539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DivisLaboratori_most_active_stocks_puts_4256539.png",
        "date": "2026-11-09 10:00:07",
        "description": "Rs 10,000 put options on Divis Laboratories Ltd attracted 3,336 contracts on 9 Nov 2026, despite the stock trading robustly at Rs 11,549. The significant distance between strike and spot price suggests the put activity is more nuanced than a straightforward bearish bet."
      }
    ],
    "total": 235,
    "sid": "509760",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "13-Nov-2026",
      "details": "submission of transcript of Q2Fy27 earnings call held on November 07 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Nov-2026",
      "details": "As Enclosed",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2026",
      "datetime": "07-Nov-2026",
      "details": "As per enclosed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

13-Nov-2026 | Source : BSE

submission of transcript of Q2Fy27 earnings call held on November 07 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-Nov-2026 | Source : BSE

As Enclosed

Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2026

07-Nov-2026 | Source : BSE

As per enclosed.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Divis Laboratories Ltd has declared 1500% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07

stock-summary
BONUS

Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15

stock-summary
RIGHTS

No Rights history available